RE:RE:RE:RE:jan 10 presentationDear wwmeinc... quote from Echelon report below: "Sernova Does Have Some Cell Pouch Clinical Data Already, But More Substantive Clinical Studies Are On The Horizon Sernova was previously conducting a three-year, twenty-patient Phase I/II first-in-human clinical trial in collaboration with the University of Alberta and Edmonton Protocol innovator AMJ Shapiro (a collaborator on the 2015 preclinical study published in Transplantation, as we described above), but the trial was never completed and is identified in the US NIHs clinical database as being terminated, with apparently three patients enrolled in the study at the time." So... you wanna call Doug Loe at Echelon and tell him he was wrong? or should I....LOL Maybe you want to go to Sernova's website and read this: https://www.sernova.com/press/?ID=166 ...where Shapiro presented data on 2 HUMAN patients... ...maybe a little more homework is in order on your part...I am not here o spew lies about the company... I like what they're doing...I watch this as I know people with diabetes...young people... as an investor I was here, but not for now...they would have to greatly improve their communication to shareholders... GOOD LUCK AND DON'T FORGET TO DO YOUR HOMEWORK.... and Sernova should have told their shareloders that they terminated that clinical trial.....enuff said!